CLINICAL SIGNIFICANCE OF DETECTION OF EGFR AND KRAS MUTATIONS IN PLASMA/PLEURAL EFFUSION IN PATIENTS WITH ADVANCED NSCLC

被引：0
|
作者：
Chen, Zhengtang [1 ]
Sun, Jie [1 ]
Ming, Hua [1 ]
Sun, Jianguo [1 ]
Wang, Xinxin [1 ]
Peng, Lina [1 ]
机构：
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
NSCLC; EGFR/KRAS mutation; tyrosine kinase inhibitor; pyrosequencing;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-003
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [1] Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery
    Parikh, Neil R.
    Likhacheva, Anna
    Pinnix, Chelsea
    Allen, Pamela K.
    Prabhu, Sujit S.
    Guha-Thakurta, Nandita
    Welsh, James W.
    Brown, Paul D.
    Chang, Eric L.
    JOURNAL OF RADIOSURGERY AND SBRT, 2015, 3 (03): : 171 - 178
  • [2] EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients
    Wang, Zhen
    Wu, Yi Long
    Zhang, Guo Chun
    Zhou, Qing
    Xu, Chong Rui
    Guo, Ai Lin
    ONKOLOGIE, 2008, 31 (04): : 174 - 178
  • [3] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
    Xiong, Liwen
    Cui, Shaohua
    Ding, Jingyan
    Sun, Yun
    Zhang, Longfu
    Zhao, Yizhuo
    Gu, Aiqin
    Chu, Tianqing
    Wang, Huimin
    Zhong, Hua
    Ye, Xin
    Gu, Yi
    Zhang, Xin
    Hu, Min
    Jiang, Liyan
    ONCOTARGET, 2017, 8 (38) : 63846 - 63856
  • [4] Intercalated EGFR and Chemotherapy in Locally Advanced NSCLC with EGFR Mutations: Data on 5 Patients and Clinical Study
    Griesinger, Frank
    Roeper, Julia
    Lueers, Anne
    Falk, Markus
    Hallas, Cora
    Tiemann, Markus
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S871 - S871
  • [5] A Radiogenomics Ensemble to Predict EGFR and KRAS Mutations in NSCLC
    Moreno, Silvia
    Bonfante, Mario
    Zurek, Eduardo
    Cherezov, Dmitry
    Goldgof, Dmitry
    Hall, Lawrence
    Schabath, Matthew
    TOMOGRAPHY, 2021, 7 (02) : 154 - 168
  • [6] Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma
    Son, Seung-Myoung
    Woo, Chang Gok
    Han, Hye Sook
    Lee, Ki Hyeong
    Lim, Young Hyun
    Lee, Ok-Jun
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (09) : 1547 - 1555
  • [7] Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
    Li, Yang-Si
    Jiang, Ben-Yuan
    Yang, Jin-Ji
    Tu, Hai-Yan
    Zhou, Qing
    Guo, Wei-Bang
    Yan, Hong-Hong
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1962 - 1969
  • [8] Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
    Guner, Gurkan
    Aktas, Burak Yasin
    Basal, Fatma Bugdayci
    Demirkazik, Ahmet
    Gursoy, Pinar
    Demirci, Umut
    Erman, Mustafa
    Yumuk, Perran Fulden
    Senler, Filiz Cay
    Cakar, Burcu
    Cicin, Irfan
    Ozturk, Akin
    Coskun, Hasan Senol
    Cubukcu, Erdem
    Isikdogan, Abdurrahman
    Olmez, Omer Fatih
    Tatli, Ali Murat
    Karaagac, Mustafa
    Sakalar, Teoman
    Eralp, Yesim
    Korkmaz, Taner
    Kilickap, Saadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13271 - 13277
  • [9] Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
    Gürkan Güner
    Burak Yasin Aktaş
    Fatma Buğdaycı Başal
    Ahmet Demirkazık
    Pınar Gürsoy
    Umut Demirci
    Mustafa Erman
    Perran Fulden Yumuk
    Filiz Çay Şenler
    Burcu Çakar
    İrfan Çiçin
    Akın Öztürk
    Hasan Şenol Coşkun
    Erdem Çubukçu
    Abdurrahman Işıkdoğan
    Ömer Fatih Ölmez
    Ali Murat Tatlı
    Mustafa Karaağaç
    Teoman Şakalar
    Yeşim Eralp
    Taner Korkmaz
    Saadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13271 - 13277
  • [10] Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC
    Chen, Xuejing
    Li, Kun
    Liu, Zichen
    Gai, Fei
    Zhu, Guanshan
    Lu, Shun
    Che, Nanying
    CANCER MEDICINE, 2021, 10 (07): : 2286 - 2292
12345